Structure |
Chemical Name |
CAS |
MF |
![Oxybutynin Impurity(MW 481Da)](/) |
Oxybutynin Impurity(MW 481Da) |
|
|
![Vitamin K1 hydroxylated Impurity](/) |
Vitamin K1 hydroxylated Impurity |
|
|
![2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid 4HCl](/) |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid 4HCl |
|
|
![Cefdinir CP Impurity F](/) |
Cefdinir CP Impurity F |
|
|
![Ceftazidime Oxide Impurity 1](/) |
Ceftazidime Oxide Impurity 1 |
|
|
![Nifuratel Impurity 21](/) |
Nifuratel Impurity 21 |
|
|
![Ornidazole Impurity 15](/CAS/20211123/GIF/105687-87-4.gif) |
Ornidazole Impurity 15 |
105687-87-4 |
C7H9ClN4O5 |
![2-(Dimethylamino)ethyl 4-methylbenzenesulfonate](/CAS/20200515/GIF/123091-15-6.gif) |
2-(Dimethylamino)ethyl 4-methylbenzenesulfonate |
123091-15-6 |
C11H17NO3S |
![Vildagliptin I Impurity](/CAS/20200611/GIF/1811569-16-0.gif) |
Vildagliptin I Impurity |
1811569-16-0 |
C7H9IN2O |
![Pregabalin Impurity 38](/CAS/20210111/GIF/1141362-94-8.gif) |
Pregabalin Impurity 38 |
1141362-94-8 |
C8H15NO2 |
![6,6'-oxybis(3-formylbenzonitrile)](/) |
6,6'-oxybis(3-formylbenzonitrile) |
|
|
![4-乙基-2,3-二氧代-N-苯基哌嗪-1-甲酰胺](/CAS/20200611/GIF/65322-79-4.gif) |
4-乙基-2,3-二氧代-N-苯基哌嗪-1-甲酰胺 |
65322-79-4 |
C13H15N3O3 |
![Cabozantinib Impurity EXA](/CAS/20210111/GIF/1431468-36-8.gif) |
Cabozantinib Impurity EXA |
1431468-36-8 |
C17H14F2N2O2 |
![Tafluprost Impurity 13](/) |
Tafluprost Impurity 13 |
|
|
![GLICLAZIDE IMPURITY B](/) |
GLICLAZIDE IMPURITY B |
|
|
![ISOPROMETHAZINE HYDROCHLORIDE](/CAS/GIF/5568-90-1.gif) |
ISOPROMETHAZINE HYDROCHLORIDE |
5568-90-1 |
C17H21ClN2S |
![2-(4-メチルフェニル)-N,N,7-トリメチルイミダゾ[1,2-a]ピリジン-3-アセトアミド](/StructureFile/ChemBookStructure22/GIF/CB5588505.gif) |
2-(4-メチルフェニル)-N,N,7-トリメチルイミダゾ[1,2-a]ピリジン-3-アセトアミド |
1346600-85-8 |
C19H21N3O |
![Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester](/CAS/20200515/GIF/1010809-39-8.gif) |
Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester |
1010809-39-8 |
C28H35N3O5S |
![Piperazine, 1,4-bis[2-[(2,4-dimethylphenyl)thio]phenyl]-](/CAS/20200515/GIF/2243045-82-9.gif) |
Piperazine, 1,4-bis[2-[(2,4-dimethylphenyl)thio]phenyl]- |
2243045-82-9 |
C32H34N2S2 |
![2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoic acid](/CAS/20210111/GIF/1640351-46-7.gif) |
2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoic acid |
1640351-46-7 |
C15H22N2O5 |
![3-Desoxyvitamin D3](/CAS/20200611/GIF/69662-75-5.gif) |
3-Desoxyvitamin D3 |
69662-75-5 |
C27H44 |
![cis-Vitamin K2](/CAS/20210111/GIF/65061-19-0.gif) |
cis-Vitamin K2 |
65061-19-0 |
C31H40O2 |
![N,N'-((5-methylisoxazole-3,4-diyl)bis(3,1-phenylenesulfonyl))dipropionamide disodium salt](/) |
N,N'-((5-methylisoxazole-3,4-diyl)bis(3,1-phenylenesulfonyl))dipropionamide disodium salt |
|
|
![Zanubrutinib Impurity](/) |
Zanubrutinib Impurity |
|
|
![(O-Isobutyryl (R)-Fesoterodine](/CAS/20210111/GIF/1795786-25-2.gif) |
(O-Isobutyryl (R)-Fesoterodine |
1795786-25-2 |
C30H43NO4 |
![Cefdinir Degradation Impurity 1](/) |
Cefdinir Degradation Impurity 1 |
|
|
![Cephalexin Impurity C2](/) |
Cephalexin Impurity C2 |
|
|
![Cefalexin Ethyl Homolog 2 Impurity](/) |
Cefalexin Ethyl Homolog 2 Impurity |
|
|
![Piperacillin Impurity P](/) |
Piperacillin Impurity P |
|
|
![1,1'-(((2R,2'R,4R,4'R)-4,4'-(oxybis(methylene))bis(2-(2,4-difluoro phenyl)tetrahydrofuran-4,2-diyl))bis(methylene))bis(1H-1,2,4-triazole)](/) |
1,1'-(((2R,2'R,4R,4'R)-4,4'-(oxybis(methylene))bis(2-(2,4-difluoro phenyl)tetrahydrofuran-4,2-diyl))bis(methylene))bis(1H-1,2,4-triazole) |
2256739-22-5 |
C28H28F4N6O3 |
![8-((R)-1-acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-1,10b-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one](/) |
8-((R)-1-acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-1,10b-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one |
|
|
![Levosimendan Impurity 16](/CAS/20210111/GIF/2290570-69-1.gif) |
Levosimendan Impurity 16 |
2290570-69-1 |
C11H12N2O |
![Tolvaptan Impurity 11](/CAS/20210111/GIF/331947-69-4.gif) |
Tolvaptan Impurity 11 |
331947-69-4 |
C16H14ClNO2 |
![(S)-2-((R)-2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide](/CAS/20211123/GIF/2432911-31-2.gif) |
(S)-2-((R)-2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2432911-31-2 |
C11H18N2O3 |
![(S)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide](/) |
(S)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
![Peramivir Impurity 17](/) |
Peramivir Impurity 17 |
|
|
![Norepinephrine EP Impurity D](/CAS/20180601/GIF/1932110-67-2.gif) |
Norepinephrine EP Impurity D |
1932110-67-2 |
C9H13NO3 |
![Olaparib Impurity 4](/) |
Olaparib Impurity 4 |
|
|
![Paclitaxel EP Impurity M](/) |
Paclitaxel EP Impurity M |
|
|
![Parecoxib Sodium Impurity H](/CAS/20210111/GIF/501093-49-8.gif) |
Parecoxib Sodium Impurity H |
501093-49-8 |
C16H14N2O4S |
![Posaconazole Impurity 10](/) |
Posaconazole Impurity 10 |
|
|
![Posaconazole Impurity 63](/CAS/20210111/GIF/208187-15-9.gif) |
Posaconazole Impurity 63 |
208187-15-9 |
C20H26F2O4 |
![(S)-4,5,6,7-Tetrahydro-N2,N6-propionyl-2,6-benzothiazolediaMine](/CAS/20200611/GIF/1373869-91-0.gif) |
(S)-4,5,6,7-Tetrahydro-N2,N6-propionyl-2,6-benzothiazolediaMine |
1373869-91-0 |
C11H17N3O2 |
![SofosBuvir impurity 62](/) |
SofosBuvir impurity 62 |
|
|
![Tamoxifen EP Impurity E](/CAS/20180703/GIF/CB83360132.gif) |
Tamoxifen EP Impurity E |
|
C26H29NO |
![Tenofovir impurity P](/) |
Tenofovir impurity P |
|
|
![Tirofiban Impurity 3](/CAS/20200515/GIF/1346918-32-8.gif) |
Tirofiban Impurity 3 |
1346918-32-8 |
C13H19NO5S |
![Trelagliptin Impurity 19](/) |
Trelagliptin Impurity 19 |
|
|
![N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide](/CAS/20180601/GIF/2028267-73-2.gif) |
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide |
2028267-73-2 |
C16H20N6O2 |
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)-](/CAS/20211123/GIF/333359-90-3.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)- |
333359-90-3 |
C20H23ClO6 |
![Flucloxacillin Sodium Impurity E](/) |
Flucloxacillin Sodium Impurity E |
|
|
![Amifostine Impurity 1](/) |
Amifostine Impurity 1 |
|
|
![Clindamycin Phosphate EP Impurity H](/) |
Clindamycin Phosphate EP Impurity H |
|
|
![2-Thia-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 3-oxo-, (4-nitrophenyl)methyl ester, (1S,4S)-](/CAS/20200611/GIF/151072-00-3.gif) |
2-Thia-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 3-oxo-, (4-nitrophenyl)methyl ester, (1S,4S)- |
151072-00-3 |
C13H12N2O5S |
![Brexpiprazole Impurity](/CAS/20200611/GIF/2116542-21-1.gif) |
Brexpiprazole Impurity |
2116542-21-1 |
C38H40N4O4S |
![4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole](/CAS/20180601/GIF/86347-62-8.gif) |
4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole |
86347-62-8 |
C14H18N2 |
![Atomoxetine EP Impurity A](/CAS/20210111/GIF/873310-33-9.gif) |
Atomoxetine EP Impurity A |
873310-33-9 |
C16H20ClNO |
![Famciclovir Impurity 12](/CAS/20180906/GIF/122497-20-5.gif) |
Famciclovir Impurity 12 |
122497-20-5 |
C12H15N5O4 |
![Levofloxacin Impurity 22](/CAS/20180601/GIF/177472-29-6.gif) |
Levofloxacin Impurity 22 |
177472-29-6 |
C20H25F2N3O4 |
![Methylprednisolone EP Impurity E](/CAS/20180601/GIF/229019-44-7.gif) |
Methylprednisolone EP Impurity E |
229019-44-7 |
C21H28O4 |
![Pantoprazole Impurity 1](/CAS/20210111/GIF/812664-93-0.gif) |
Pantoprazole Impurity 1 |
812664-93-0 |
C16H14ClF2N3O4S |
![Ticagrelor Related Compound 38D-Tartrate](/CAS/20200611/GIF/2165881-71-8.gif) |
Ticagrelor Related Compound 38D-Tartrate |
2165881-71-8 |
C10H19NO4 |
![1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE](/CAS/20180601/GIF/105685-06-1.gif) |
1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE |
105685-06-1 |
C12H14N2S |
![4-methyl-N-(2-methyl-5-nitrophenyl)-6-(pyridin-3-yl)pyrimidin-2-amine](/CAS/20180703/GIF/CB83382314.gif) |
4-methyl-N-(2-methyl-5-nitrophenyl)-6-(pyridin-3-yl)pyrimidin-2-amine |
|
C17H15N5O2 |
![trans-Carboprost](/CAS/20180808/GIF/76498-29-8.gif) |
trans-Carboprost |
76498-29-8 |
C21H36O5 |
![N-[[2'-(1H-テトラゾール-5-イル)[1,1'-ビフェニル]-4-イル]メチル]アミン](/CAS/20180808/GIF/147225-68-1.gif) |
N-[[2'-(1H-テトラゾール-5-イル)[1,1'-ビフェニル]-4-イル]メチル]アミン |
147225-68-1 |
C14H13N5 |
![MFFANMLJBOSKIX-UHFFFAOYSA-N](/CAS/20200611/GIF/352457-34-2.gif) |
MFFANMLJBOSKIX-UHFFFAOYSA-N |
352457-34-2 |
C9H13N5O2 |
![4,4',4''-メチリジントリスベンゾニトリル (LETROZOLE IMPURITY)](/CAS/GIF/113402-31-6.gif) |
4,4',4''-メチリジントリスベンゾニトリル (LETROZOLE IMPURITY) |
113402-31-6 |
C22H13N3 |
![methyl (2E)-3-(methylamino)but-2-enoate](/CAS/20180601/GIF/21759-69-3.gif) |
methyl (2E)-3-(methylamino)but-2-enoate |
21759-69-3 |
C6H11NO2 |
![Entecavir Impurity 5](/CAS/20210111/GIF/84868-56-4.gif) |
Entecavir Impurity 5 |
84868-56-4 |
C21H20O2 |
![Bisoprolol-d5](/CAS/20180601/GIF/1189881-87-5.gif) |
Bisoprolol-d5 |
1189881-87-5 |
C18H31NO4 |
![4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)-BENZOIC ACID METHYL ESTER](/CAS/20180601/GIF/33947-97-6.gif) |
4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)-BENZOIC ACID METHYL ESTER |
33947-97-6 |
C14H21NO4 |
![3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-[1-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]pentan-2-yl]-1,3-diazaspiro[4.4]non-1-en-4-one](/CAS/20180601/GIF/1346598-52-4.gif) |
3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-[1-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]pentan-2-yl]-1,3-diazaspiro[4.4]non-1-en-4-one |
1346598-52-4 |
C39H38N10O |
![5-METHYL-3-NITROMETHYL-HEXANOIC ACID](/StructureFile/ChemBookStructure9/GIF/CB8391168.gif) |
5-METHYL-3-NITROMETHYL-HEXANOIC ACID |
181289-21-4 |
C8H15NO4 |
![N-メチル-4-(3,4-ジクロロフェニル)テトラリン-1-アミン](/CAS/GIF/140631-53-4.gif) |
N-メチル-4-(3,4-ジクロロフェニル)テトラリン-1-アミン |
140631-53-4 |
C17H17Cl2N |
![(S)-ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate](/CAS/20180703/GIF/870695-39-9.gif) |
(S)-ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate |
870695-39-9 |
C8H13NO4 |
![4-(3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-hydroxybenzyl)phthalazin-1(2H)-one](/CAS/20180703/GIF/CB83955921.gif) |
4-(3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-hydroxybenzyl)phthalazin-1(2H)-one |
|
C24H24N4O4 |
![Diquafosol Impurity 2](/CAS/20210111/GIF/63785-59-1.gif) |
Diquafosol Impurity 2 |
63785-59-1 |
C18H25N4O20P3 |
![N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine](/CAS/20210305/GIF/2459302-87-3.gif) |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine |
2459302-87-3 |
C26H26Cl2N8 |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180703/GIF/1598416-08-0.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-08-0 |
C22H18Cl2N2O5 |
![PANTOPRAZOLE N-OXIDE SODIUM SALT](/StructureFile/ChemBookStructure9/GIF/CB8399371.gif) |
PANTOPRAZOLE N-OXIDE SODIUM SALT |
1279822-90-0 |
C16H16F2N3NaO5S |
![3-ヒドロキシチオベンズアミド](/CAS/GIF/104317-54-6.gif) |
3-ヒドロキシチオベンズアミド |
104317-54-6 |
C7H7NOS |
![Tadalafil impurity 38](/CAS/20200515/GIF/185750-07-6.gif) |
Tadalafil impurity 38 |
185750-07-6 |
C14H15ClN2O3 |
![Fulvestrant impurity H](/) |
Fulvestrant impurity H |
|
|
![1-(5-(2-fluorophenyl)-1-(pyridin-2-ylsulfonyl)-1H-pyrrol-3-yl)-N- methylmethanamine fumarate](/CAS/20200401/GIF/928615-46-7.gif) |
1-(5-(2-fluorophenyl)-1-(pyridin-2-ylsulfonyl)-1H-pyrrol-3-yl)-N- methylmethanamine fumarate |
928615-46-7 |
C17H16FN3O2S |
![4-アミノ-1-メチル-5-プロピル-1H-ピラゾール-3-カルボキサミド](/CAS/GIF/247583-78-4.gif) |
4-アミノ-1-メチル-5-プロピル-1H-ピラゾール-3-カルボキサミド |
247583-78-4 |
C8H14N4O |
![カペシタビン-D11](/StructureFile/ChemBookStructure8/GIF/CB8457758.gif) |
カペシタビン-D11 |
1132662-08-8 |
C15H13D11FN3O6 |
![Bendamustine Related Impurity 2](/) |
Bendamustine Related Impurity 2 |
|
|
![Bendamustine Related Impurity 7](/) |
Bendamustine Related Impurity 7 |
|
|
![Bortezomib Impurity 25](/) |
Bortezomib Impurity 25 |
|
|
![Bortezomib Impurity 40](/) |
Bortezomib Impurity 40 |
|
|
![Edoxaban Impurity 28 (1R,2R,4R)](/CAS/20200611/GIF/1255529-38-4.gif) |
Edoxaban Impurity 28 (1R,2R,4R) |
1255529-38-4 |
C21H30ClN5O5 |
![Linagliptin Impurity 31](/) |
Linagliptin Impurity 31 |
|
|
![Olopatadine Impurity 1](/CAS/20210111/GIF/66801-40-9.gif) |
Olopatadine Impurity 1 |
66801-40-9 |
C15H10O4 |
![Paroxetine Impurity 12](/) |
Paroxetine Impurity 12 |
|
|
![Rivaroxaban Impurity 69 DiHCl](/) |
Rivaroxaban Impurity 69 DiHCl |
|
|
![Sitafloxacin Impurity 5](/CAS/20210111/GIF/1630983-99-1.gif) |
Sitafloxacin Impurity 5 |
1630983-99-1 |
C15H12ClF4NO3 |
![Ticagrelor Related Compound 92](/) |
Ticagrelor Related Compound 92 |
|
|
![Valsartan Impurity 10](/CAS/20200401/GIF/1314799-74-0.gif) |
Valsartan Impurity 10 |
1314799-74-0 |
C23H29N5O |
![Vonoprazan Impurity 23](/) |
Vonoprazan Impurity 23 |
|
|